Intas gets DCGI nod for clinical trials of hyperimmune globulin for COVID-19 treatment
It can be an important therapeutic option that can potentially help combat the disease until a vaccine is available, states the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drug Controller General of India
CDSCO allows import of COVID-19 drugs with less than 60 per cent shelf life
The import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the…
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH
Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…
AstraZeneca India receives marketing permission for QTERN
Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…
DGCI advocates for massive investment in drug research projects
The DGCI, Dr V G Somani, called for more investment in R&D during an IPA convention in New Delhi which was attended by over…
Govt appoints VG Somani as new Drug Controller General
He will be be India's first full time DCGI in nearly two years after Dr G N Singh left the position in early 2018